evenfolioETF Details
ARK ETF Trust·Health·ARKG · Cboe BZX
ARK Genomic Revolution ETF (ARKG)
- Price
- $51.40
- —30 Oct 2026
- Assets
- $2.2B
- Total net assets
- Expense ratio
- 0.75%
- Category 1.00%
- Yield
- 0.00%
- Trailing distributions
- 1Y return
- 72.6%+43.8%
- Category 28.8%
- 3Y CAGR
- 31.8%+10.3%
- Category 21.5%
- 5Y CAGR
- -7.2%-11.3%
- Category 4.1%
Loading NAV history…
ARK Genomic Revolution ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -5.2% | +33.3% | +69.6% | +77.4% | +72.6% | +31.8% | -7.2% | +12.6% | +8.8% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -8.8% | +23.4% | +46.6% | +57.0% | +43.8% | +10.3% | -11.3% | +1.8% | -2.8% |
Holdings
The 10 largest positions make up 62.4% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| TWST | Twist Bioscience Corp | 10.31% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 10.02% |
| TEM | Tempus AI Inc Class A common stock | 8.93% |
| CRSP | CRISPR Therapeutics AG | 5.24% |
| ABSI | Absci Corp | 5.06% |
| PSNL | Personalis Inc | 4.88% |
| GH | Guardant Health Inc | 4.61% |
| NTRA | Natera Inc | 4.53% |
| ILMN | Illumina Inc | 4.50% |
| CDNA | CareDx Inc | 4.34% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 5.7
- P/S
- 13.7
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.8%
- Cash0.2%
ETF details
- Issuer
- ARK ETF Trust
- Category
- Equity · Health
- Ticker
- ARKG
- Exchange
- Cboe BZX
- Inception
- 31 Oct 2014 (12.0 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.75% (category 1.00%)
- Holdings turnover
- 34% (category 51%)
- Distribution yield
- 0.00%
- Beta, 3 years
- 2.21
- Total net assets
- $2.2B
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- IHE · iShares U.S. Pharmaceuticals ETFiShares · $1.6B · ER 0.37%5Y 13.3%
- IHF · iShares U.S. Healthcare Providers ETFiShares · $1.4B · ER 0.37%5Y 2.5%
- FXH · First Trust Health Care AlphaDEX FundFirst Trust · $1.1B · ER 0.61%5Y 3.0%
- FTXH · First Trust Nasdaq Pharmaceuticals ETFFirst Trust · $1.1B · ER 0.60%5Y 12.6%
- PBPH · Portfolio Building Block World Pharma and Biotech Index ETFPortfolio Building Block ETFs · $1B · ER 0.13%
- PPH · VanEck Pharmaceutical ETFVanEck · $1B · ER 0.36%5Y 11.8%